pAAVone-AAV2-CMV-eGFP Citations (1)

Originally described in: AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities.
Yang R, Tran NT, Chen T, Cui M, Wang Y, Sharma T, Liu Y, Zhang J, Yuan X, Zhang D, Chen C, Shi Z, Wang L, Dai Y, Zaidi H, Liang J, Chen M, Jaijyan D, Hu H, Wang B, Xu C, Hu W, Gao G, Yu D, Tai PWL, Wang Q Mol Ther Nucleic Acids. 2025 May 14;36(2):102563. doi: 10.1016/j.omtn.2025.102563. eCollection 2025 Jun 10. PubMed Journal

---

Articles Citing pAAVone-AAV2-CMV-eGFP

Articles
Controlled spatial and temporal release of neurotrophic growth factor from genetically modified tissue engineering living scaffolds. Lee HH, Lien SE, Alpizar Vargas V, Shultz RB, Laimo FA, Katiyar KS, Cullen DK. J Tissue Eng. 2025 Nov 18;16:20417314251389333. doi: 10.1177/20417314251389333. eCollection 2025 Jan-Dec. PubMed

If you have published an article using this material, please email us at to have your article added to this page.